NovoCure Limited (NVCR) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

NovoCure Limited (NVCR)

17.49

-0.11 (0.63%)

as of Jun 16, 2026, 8:00:00 pm Market Open.

14 watching

DON'T BUY

He used to like this company a lot, but they fail to make money. Revenues are flat.

BUY

The medical community doesn't recognize this company, but when it does the stock will double.

BUY

Recommended this in early-2018. Why has it doubled recently? It works. A friend of his used NVCR medical machines, and his life was extended by three years.

Showing 1 to 3 of 3 entries

NovoCure Limited (NVCR) Frequently Asked Questions

What is NovoCure Limited stock symbol?

NovoCure Limited is a American stock, trading under the symbol NVCR (previously NVCR-Q on Stockchase) on the NASDAQ (NVCR). It is usually referred to as NASDAQ:NVCR or NVCR

Is NovoCure Limited a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on NVCR (previously NVCR-Q on Stockchase) on Stockchase. Read the latest expert commentary for NovoCure Limited.

Is NovoCure Limited a good investment or a top pick?

NovoCure Limited was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for NovoCure Limited.

Why is NovoCure Limited stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for NovoCure Limited.

Is NovoCure Limited worth watching?

NovoCure Limited is followed by 14 investors on Stockchase and is a trending stock that is worth watching.

What is NovoCure Limited stock price?

On 2026-06-16, NovoCure Limited (NVCR) stock closed at a price of $17.49.

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

NovoCure Limited (NVCR)